Kalowski Lee, CFO and President of Q32 Bio Inc. ($QTTB), sold shares on the open market three times in the last year, totaling about $57,000. The most recent sale occurred on February 25, 2026. These sales rank 10,256th among nearly 12,000 insiders, well below the average of $8.6 million per seller and 6.4 transactions. Lee made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | Q32 Bio Inc. | $QTTB | Kalowski Lee | CFO and President | A | Common Stock | 53250 | $0.00 | 89,193.0000 | 12,304,352 | 148.15% | 0.43% |
| Feb. 25, 2026 | Q32 Bio Inc. | $QTTB | Kalowski Lee | CFO and President | S | Common Stock | 3995 | $4.51 | 35,943.0000 | 12,304,352 | 10.00% | 0.03% |
| Dec. 2, 2025 | Q32 Bio Inc. | $QTTB | Kalowski Lee | CFO and President | S | Common Stock | 9072 | $3.46 | 39,938.0000 | 12,304,352 | 18.51% | 0.07% |
| Aug. 26, 2025 | Q32 Bio Inc. | $QTTB | Kalowski Lee | CFO and President | S | Common Stock | 4240 | $1.80 | 49,010.0000 | 12,197,615 | 7.96% | 0.03% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Kalowski Lee | CFO and President | A | Stock Option (Right to Buy) | 161323 | $0.00 | 161,323.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Kalowski Lee | CFO and President | D | Stock Option (Right to Buy) | 16901 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Kalowski Lee | CFO and President | A | Stock Option (Right to Buy) | 16901 | $0.00 | 16,901.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Kalowski Lee | CFO and President | D | Stock Option (Right to Buy) | 161323 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Kalowski Lee | CFO and President | A | Common Stock | 53250 | $0.00 | 53,250.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | Q32 Bio Inc. | $QTTB | Kalowski Lee | CFO and President | A | Stock Option (Right to Buy) | 161323 | $0.00 | 161,323.0000 | 0 | 9999.99% | 0.00% |
| April 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Kalowski Lee | President and CFO | S | Ordinary Shares | 376 | $21.11 | 30,309.0000 | 30,001,725 | 1.23% | 0.00% |
| Jan. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Kalowski Lee | President and CFO | A | Ordinary Shares | 17500 | $0.00 | 32,500.0000 | 29,660,659 | 116.67% | 0.06% |
| Jan. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Kalowski Lee | President and CFO | S | Ordinary Shares | 1815 | $29.06 | 30,685.0000 | 29,660,659 | 5.58% | 0.01% |
| Jan. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Kalowski Lee | President and CFO | A | Employee Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 29,660,659 | 9999.99% | 0.12% |